Get the Stockscreener App
42.63
1.21%
-0.52
After Hours:
42.63
Xenon Pharmaceuticals Inc Stock (XENE) Latest News
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock Holdings Lifted by Braidwell LP - MarketBeat
Vestal Point Capital LP Increases Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Investors Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Purchased by Ally Bridge Group NY LLC - MarketBeat
Natixis Advisors LLC Increases Stock Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
(XENE) Trading Signals - Stock Traders Daily
Loomis Sayles & Co. L P Buys 46,964 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals' SWOT analysis: stock poised for breakthrough in epilepsy - Investing.com
Xenon Pharmaceuticals Unveils New Data at AES 2024 - TipRanks
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024 - The Manila Times
Westfield Capital Management Co. LP Buys 26,054 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Director Sells $200,922.28 in Stock - MarketBeat
Xenon Pharmaceuticals director sells $200,946 in stock - Investing.com India
Xenon Pharmaceuticals director sells $200,946 in stock By Investing.com - Investing.com Australia
First Turn Management LLC Sells 14,658 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Investors Eye Opportunities With Xenon Pharmaceuticals - Evrim Ağacı
Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap DownHere's What Happened - MarketBeat
Equities Analysts Issue Forecasts for XENE FY2024 Earnings - MarketBeat
FY2024 EPS Estimates for XENE Reduced by Cantor Fitzgerald - MarketBeat
How to Take Advantage of moves in (XENE) - Stock Traders Daily
Q1 Earnings Forecast for XENE Issued By HC Wainwright - MarketBeat
What is Wedbush's Estimate for XENE FY2024 Earnings? - MarketBeat
Leerink Partnrs Has Pessimistic View of XENE FY2024 Earnings - MarketBeat
Needham & Company LLC Reaffirms Buy Rating for Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World
Stock Traders Purchase Large Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat
GSA Capital Partners LLP Purchases 30,830 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus - MSN
Xenon to Present at Upcoming Investor Conferences - The Manila Times
Xenon Pharmaceuticals (NASDAQ:XENE) Announces Quarterly Earnings Results - MarketBeat
Needham & Company LLC Reaffirms "Buy" Rating for Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2024 Earnings Call Transcript - Insider Monkey
Xenon Pharmaceuticals: Q3 Earnings Snapshot - mySA
Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlight - GuruFocus.com
Xenon Reports Q3 2024 Financial Results and Business Update - The Manila Times
Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo Finance
Xenon Pharmaceuticals Reports Q3 2024 Progress and Outlook - TipRanks
Xenon Pharmaceuticals Reports $803M Cash Position, Advances Epilepsy Drug Pipeline | XENE Stock News - StockTitan
Xenon Advances Epilepsy and Depression Programs - TipRanks
Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2 - GuruFocus.com
TimesSquare Capital Management LLC Purchases 23,800 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Fiera Capital Corp Sells 28,679 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals (XENE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Xenon to Report Q3 2024 Financial Results on November 12, 2024 - StockTitan
Harbor Capital Advisors Inc. Buys 23,947 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Allspring Global Investments Holdings LLC Sells 21,269 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Defense World
New Horizons in Tonic-clonic Seizure Market Exploring Future - openPR
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by abrdn plc - MarketBeat
Repligen Co. (NASDAQ:RGEN) Position Boosted by Blue Trust Inc. - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of “Buy” by Brokerages - Defense World
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Creative Planning - Defense World
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):